APTAMIR
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Apr 2019)
What this means for you
This application is over — abandoned 22 Apr 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86457201
- Mark type
- Design + words
- Filed
- 18 Nov 2014
- Published for opposition
- 14 Jul 2015
- Abandoned
- 22 Apr 2019
- Attorney of record
- Alicia Morris Groos
Goods and services
- Class 005 — Pharmaceuticals: Medicinal and biological preparations for pharmaceutical, clinical or medical treatment, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and/or degradation processes related thereto for the treatment of cardiovascular diseases, metabolic diseases, overweight, obesity, diabetes mellitus, dyslipidemia, liver steatosis (fatty liver disease), steatohepatitis, non-alcoholic fatty liver disease, atherosclerosis, and chronic visceral inflammation
Owner
- AptamiR Therapeutics, Inc., Naples, FL, US
- AptamiR Therapeutics, Inc., Austin, TX, US
Prosecution history
- 22 Apr 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Apr 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Sept 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Sept 2018 — SOU EXTENSION 5 GRANTED
- 29 Aug 2018 — SOU EXTENSION 5 FILED
- 07 Sept 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Aug 2018 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2018 — SOU EXTENSION 4 GRANTED
- 26 Feb 2018 — SOU EXTENSION 4 FILED
- 26 Feb 2018 — SOU TEAS EXTENSION RECEIVED
- 25 Aug 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2017 — SOU EXTENSION 3 GRANTED
- 23 Aug 2017 — SOU EXTENSION 3 FILED
- 23 Aug 2017 — SOU TEAS EXTENSION RECEIVED